Danaher Corporation (NYSE:DHR) Announces $0.32 Quarterly Dividend

Danaher Corporation (NYSE:DHR) declared a quarterly dividend on Tuesday, December 9th. Shareholders of record on Friday, December 26th will be given a dividend of 0.32 per share by the conglomerate on Friday, January 30th. This represents a c) annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, December 26th.

Danaher has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 2 years. Danaher has a dividend payout ratio of 14.9% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Danaher to earn $8.57 per share next year, which means the company should continue to be able to cover its $1.28 annual dividend with an expected future payout ratio of 14.9%.

Danaher Trading Up 0.3%

Shares of DHR stock opened at $223.92 on Wednesday. Danaher has a 12-month low of $171.00 and a 12-month high of $258.23. The company has a market capitalization of $158.16 billion, a PE ratio of 46.33, a price-to-earnings-growth ratio of 4.36 and a beta of 0.89. The firm has a 50 day moving average price of $217.50 and a two-hundred day moving average price of $205.01. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.71 earnings per share. As a group, analysts predict that Danaher will post 7.63 earnings per share for the current year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.